In Indiana, Liberation Labs has officially broken ground on its inaugural precision fermentation biomanufacturing facility. Sited in Richmond, the facility boasts capacity of 600,000 liters and a fully dedicated downstream process. It is capable of producing biobased proteins and other essential building-block ingredients.
“This is a momentous occasion not only for Liberation Labs but for the future of bioproducts,” said Mark Warner, co-founder and CEO of Liberation Labs. “Despite growing consumer interest in biobased ingredients, the industry has yet to fully deliver on its promises. We believe that our purpose-built biomanufacturing facility will bridge this gap and usher in a new era of advanced bioproducts that enhance our lives, including food, materials, and yet-to-be-discovered breakthroughs.”
Commercial production is expected to commence by the end of 2024.